Erythropoietin-derived nerve support and inflammation-modulating peptide for neuropathic pain and nerve repair protocols.

Product Overview

ARA-290 (cibinetide) is an erythropoietin-derived peptide designed for tissue-protective and innate-repair signalling without red-blood-cell stimulating effects. Used for nerve support, inflammation modulation and regenerative support. Benefits build over weeks with peak effects from weeks 2-3 onwards. Use 5 days per week with 2 days break.

Composition

ARA-290 30mg

Strength & Volume

30mg | 3mL

Dosing System

300-click pen system

Per Click/Unit

0.10mg per click (10 units = 1.0mg)

Beginner Dose

10 units (1.0mg) daily

Standard Dose

20 units (2.0mg) daily

Max Dose

40 units (4.0mg) daily

Frequency

5 days per week (2 days break)

Cycle Length & Off Period

6-12 weeks (Protocols 1/2) | 4-6 weeks (Protocol 3) | Off Period: 4 weeks

Key Benefits

Nerve support | Nerve repair | Inflammation modulation | Neuropathic pain support | Regenerative support

Expected Outcomes

Support for neuropathic pain protocols / nerve repair and regeneration / improved inflammation modulation / structured recovery support / gradual benefit building from weeks 2-3.

Warnings

Not suitable under 18 / during pregnancy / while breastfeeding. Always consult a healthcare professional. KEEP REFRIGERATED. Disposable pen option is R50 extra.

Storage

Refrigerate at 2-8°C. Do not freeze.

Administration

Subcutaneous injection. 5 days on / 2 days off.

Kit Contents

1 x ARA-290 30mg Cartridge

Related Products

BPC-157 | TB-500 | KPV | MOTS-C